West Pharmaceutical Services, Inc.WSTNYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$276.40M
↑ 13% above average
Average (9y)
$244.62M
Historical baseline
Range
High:$439.40M
Low:$49.20M
CAGR
+14.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $276.40M | -33.3% |
| 2023 | $414.50M | -5.7% |
| 2022 | $439.40M | +32.9% |
| 2021 | $330.60M | +10.9% |
| 2020 | $298.10M | +23.8% |
| 2019 | $240.80M | +30.9% |
| 2018 | $183.90M | +38.8% |
| 2017 | $132.50M | +169.3% |
| 2016 | $49.20M | -39.1% |
| 2015 | $80.80M | - |